𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Non toxic combination chemotherapy for 115 patients with carcinomas of unknown primary (CUP) site

✍ Scribed by Mousseau, M.; Swiercz, P.; Schaerer, R.; Lutz, J.M.

Book ID
122752322
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
166 KB
Volume
29
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Gemcitabine and docetaxel as front-line
Gemcitabine and docetaxel as front-line chemotherapy in patients with carcinoma of an unknown primary site
✍ Damien Pouessel; StΓ©phane Culine; Catherine Becht; Marc Ychou; Gilles Romieu; Mi πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 70 KB πŸ‘ 1 views

## Abstract ## BACKGROUND The current study was performed to evaluate the efficacy and toxicity of a noncisplatin‐based chemotherapy regimen combining gemcitabine and docetaxel as front‐line chemotherapy for patients with carcinoma of an unknown primary site. ## METHODS Patients were to receive

Gemcitabine and docetaxel as front-line
Gemcitabine and docetaxel as front-line chemotherapy in patients with carcinoma of an unknown primary site
✍ Alberto MuΓ±oz; JosΓ© RamΓ³n BarcelΓ³; Guillermo LΓ³pez-Vivanco πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 67 KB πŸ‘ 1 views

tional RCC and extensively cystic Bosniak Grade 2 or 3 disease, which may be difficult to diagnose reliably using either fine-needle or core-needle biopsy. Correlation of the results presented by Volpe et al. with the additional findings discussed in the current correspondence may be useful.